These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22938934)

  • 1. Imaging of thyrotoxicosis.
    Sipos JA; Kahaly GJ
    Am J Med; 2012 Sep; 125(9):S1-2. PubMed ID: 22938934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthyroidism during pregnancy--the role of measuring maternal TSH receptor antibodies and foetal ultrasound monitoring.
    Gietka-Czernel M; Dębska M; Kretowicz P; Zgliczyński W; Ołtarzewski M
    Endokrynol Pol; 2014; 65(4):259-68. PubMed ID: 25185847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune thyrotoxicosis: diagnostic challenges.
    Ponto KA; Kahaly GJ
    Am J Med; 2012 Sep; 125(9):S1. PubMed ID: 22938935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the measurement of inferior thyroid artery blood flow velocity by color-flow Doppler ultrasonography useful for differential diagnosis between gestational transient thyrotoxicosis and Graves' disease? A prospective study.
    Zuhur SS; Ozel A; Velet S; Buğdacı MS; Cil E; Altuntas Y
    Clinics (Sao Paulo); 2012; 67(2):125-9. PubMed ID: 22358236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of thyrotoxicosis during pregnancy with color flow Doppler sonography.
    Hari Kumar KV; Vamsikrishna P; Verma A; Muthukrishnan J; Meena U; Modi KD
    Int J Gynaecol Obstet; 2008 Aug; 102(2):152-5. PubMed ID: 18456267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy.
    Cohen O; Pinhas-Hamiel O; Sivan E; Dolitski M; Lipitz S; Achiron R
    Prenat Diagn; 2003 Sep; 23(9):740-2. PubMed ID: 12975785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and successful in utero treatment of a fetal goitrous hyperthyroidism caused by maternal Graves' disease. A case report.
    Heckel S; Favre R; Schlienger JL; Soskin P
    Fetal Diagn Ther; 1997; 12(1):54-8. PubMed ID: 9101225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent fetal thyrotoxicosis in a woman with Graves' disease: case report.
    Ting MK; Hsu BR; Huang YY; Lin JD; Chen TC
    Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):492-7. PubMed ID: 10584424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.
    Tagami T; Hagiwara H; Kimura T; Usui T; Shimatsu A; Naruse M
    Thyroid; 2007 Aug; 17(8):767-72. PubMed ID: 17651013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ultrasonography in the differential diagnosis of thyrotoxicosis: a noninvasive, cost-effective, and widely available but underutilized diagnostic tool.
    Alzahrani AS; Ceresini G; Aldasouqi SA
    Endocr Pract; 2012; 18(4):567-78. PubMed ID: 22440986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal Thyrotropin Receptor Antibody Concentration and the Risk of Fetal and Neonatal Thyrotoxicosis: A Systematic Review.
    van Dijk MM; Smits IH; Fliers E; Bisschop PH
    Thyroid; 2018 Feb; 28(2):257-264. PubMed ID: 29325496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of neonatal Graves' disease--prediction, prevention and treatment].
    Matsuura N
    Nihon Rinsho; 2006 Dec; 64(12):2303-7. PubMed ID: 17154096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
    Popoveniuc G; Sharma M; Devdhar M; Wexler JA; Carroll NM; Wartofsky L; Burman KD
    Thyroid; 2010 Sep; 20(9):1015-8. PubMed ID: 20718680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthyroidism in pregnancy.
    Mestman JH
    Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):394-401. PubMed ID: 22922367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
    Kahaly GJ; Grebe SK; Lupo MA; McDonald N; Sipos JA
    Am J Med; 2011 Jun; 124(6):S2-3. PubMed ID: 21605717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hyperfunction during pregnancy.
    Glinoer D
    Thyroid; 1998 Sep; 8(9):859-64. PubMed ID: 9777758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring.
    Luton D; Le Gac I; Vuillard E; Castanet M; Guibourdenche J; Noel M; Toubert ME; Léger J; Boissinot C; Schlageter MH; Garel C; Tébeka B; Oury JF; Czernichow P; Polak M
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6093-8. PubMed ID: 16118343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin receptor autoantibodies in Graves' disease.
    Schott M; Scherbaum WA; Morgenthaler NG
    Trends Endocrinol Metab; 2005 Jul; 16(5):243-8. PubMed ID: 15950483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased size and vascularisation, plus decreased echogenicity, of foetal thyroid in two-dimensional ultrasonography caused by maternal Graves' disease.
    Gietka-Czernel M; Dębska M; Kretowicz P; Jastrzębska H; Zgliczyński W
    Endokrynol Pol; 2014; 65(1):64-8. PubMed ID: 24549604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.